These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 27508303)

  • 1. IRF1 Downregulation by Ras/MEK Is Independent of Translational Control of IRF1 mRNA.
    Komatsu Y; Derwish L; Hirasawa K
    PLoS One; 2016; 11(8):e0160529. PubMed ID: 27508303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogenic Ras inhibits IRF1 to promote viral oncolysis.
    Komatsu Y; Christian SL; Ho N; Pongnopparat T; Licursi M; Hirasawa K
    Oncogene; 2015 Jul; 34(30):3985-93. PubMed ID: 25347735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restoration of IRF1-dependent anticancer effects by MEK inhibition in human cancer cells.
    AbuSara N; Razavi S; Derwish L; Komatsu Y; Licursi M; Hirasawa K
    Cancer Lett; 2015 Feb; 357(2):575-81. PubMed ID: 25497010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Negative regulation of the alpha interferon-induced antiviral response by the Ras/Raf/MEK pathway.
    Battcock SM; Collier TW; Zu D; Hirasawa K
    J Virol; 2006 May; 80(9):4422-30. PubMed ID: 16611902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated Ras/MEK inhibits the antiviral response of alpha interferon by reducing STAT2 levels.
    Christian SL; Collier TW; Zu D; Licursi M; Hough CM; Hirasawa K
    J Virol; 2009 Jul; 83(13):6717-26. PubMed ID: 19386709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MEK reduces cancer-specific PpIX accumulation through the RSK-ABCB1 and HIF-1α-FECH axes.
    Chelakkot VS; Liu K; Yoshioka E; Saha S; Xu D; Licursi M; Dorward A; Hirasawa K
    Sci Rep; 2020 Dec; 10(1):22124. PubMed ID: 33335181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of beta3-integrin gene expression by sustained activation of the Ras-regulated Raf-MEK-extracellular signal-regulated kinase signaling pathway.
    Woods D; Cherwinski H; Venetsanakos E; Bhat A; Gysin S; Humbert M; Bray PF; Saylor VL; McMahon M
    Mol Cell Biol; 2001 May; 21(9):3192-205. PubMed ID: 11287623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The RAS/Raf1/MEK/ERK signaling pathway facilitates VSV-mediated oncolysis: implication for the defective interferon response in cancer cells.
    Noser JA; Mael AA; Sakuma R; Ohmine S; Marcato P; Lee PW; Ikeda Y
    Mol Ther; 2007 Aug; 15(8):1531-6. PubMed ID: 17505473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ras/MEK pathway is required for NGF-induced expression of tyrosine hydroxylase gene.
    Suzuki T; Kurahashi H; Ichinose H
    Biochem Biophys Res Commun; 2004 Mar; 315(2):389-96. PubMed ID: 14766220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of IFN-induced transcription underlies IFN defects generated by activated Ras/MEK in human cancer cells.
    Christian SL; Zu D; Licursi M; Komatsu Y; Pongnopparat T; Codner DA; Hirasawa K
    PLoS One; 2012; 7(9):e44267. PubMed ID: 22970192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of PTEN expression is essential for antiapoptosis and cellular transformation by oncogenic Ras.
    Vasudevan KM; Burikhanov R; Goswami A; Rangnekar VM
    Cancer Res; 2007 Nov; 67(21):10343-50. PubMed ID: 17974977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depletion of ERK2 but not ERK1 abrogates oncogenic Ras-induced senescence.
    Shin J; Yang J; Lee JC; Baek KH
    Cell Signal; 2013 Dec; 25(12):2540-7. PubMed ID: 23993963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of c-fos gene transcription in cells transformed by E1A and cHa-ras oncogenes: a role of sustained activation of MAP/ERK kinase cascade and of inactive chromatin structure at c-fos promoter.
    Kukushkin AN; Abramova MV; Svetlikova SB; Darieva ZA; Pospelova TV; Pospelov VA
    Oncogene; 2002 Jan; 21(5):719-30. PubMed ID: 11850800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasound stimulates NF-kappaB activation and iNOS expression via the Ras/Raf/MEK/ERK signaling pathway in cultured preosteoblasts.
    Hou CH; Lin J; Huang SC; Hou SM; Tang CH
    J Cell Physiol; 2009 Jul; 220(1):196-203. PubMed ID: 19288477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon regulatory factor 1 and a variant of heterogeneous nuclear ribonucleoprotein L coordinately silence the gene for adhesion protein CEACAM1.
    Dery KJ; Silver C; Yang L; Shively JE
    J Biol Chem; 2018 Jun; 293(24):9277-9291. PubMed ID: 29720400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The downregulation of the pro-apoptotic protein Par-4 is critical for Ras-induced survival and tumor progression.
    Barradas M; Monjas A; Diaz-Meco MT; Serrano M; Moscat J
    EMBO J; 1999 Nov; 18(22):6362-9. PubMed ID: 10562548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible regulation of the transformed phenotype of ornithine decarboxylase- and ras-overexpressing cells by dominant-negative mutants of c-Jun.
    Kielosto M; Nummela P; Katainen R; Leaner V; Birrer MJ; Hölttä E
    Cancer Res; 2004 Jun; 64(11):3772-9. PubMed ID: 15172983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of p202, a modulator of apoptosis, during oncogenic transformation of NIH 3T3 cells by activated H-Ras (Q61L) contributes to cell survival.
    Xin H; Geng Y; Pramanik R; Choubey D
    J Cell Biochem; 2003 Jan; 88(1):191-204. PubMed ID: 12461788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenic Ras-mediated downregulation of Clast1/LR8 is involved in Ras-mediated neoplastic transformation and tumorigenesis in NIH3T3 cells.
    Ryu SH; Kim KH; Kim HB; Kim MH; Kim NH; Kang Y; Hyun JW; Seo HJ; Jun JY; You HJ
    Cancer Sci; 2010 Sep; 101(9):1990-6. PubMed ID: 20550525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RAF suppression synergizes with MEK inhibition in KRAS mutant cancer cells.
    Lamba S; Russo M; Sun C; Lazzari L; Cancelliere C; Grernrum W; Lieftink C; Bernards R; Di Nicolantonio F; Bardelli A
    Cell Rep; 2014 Sep; 8(5):1475-83. PubMed ID: 25199829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.